Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Berk

Showing results (351-360 of 398) with videos related to

Pageof 40
Sort By:
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|July 24, 2018
A library of ATTR amyloidosis patient-specific induced pluripotent stem cells for disease modelling and in vitro testing of novel therapeuticsRichard M Giadone, Jessica D Rosarda, Prithvi Reddy Akepati, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|August 16, 2011
The diflunisal trial: update on study drug tolerance and disease progressionJ L Berk, P J Dyck, L Obici, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 6, 2012
Phase I/IIa trial of the mammalian target of rapamycin inhibitor ridaforolimus (AP23573; MK-8669) administered orally in patients with refractory or advanced malignancies and sarcomaM M Mita, E Poplin, C D Britten, et al.
ACS Applied Materials & Interfaces|April 14, 2021
Rapid Visual Authentication Based on DNA Strand DisplacementKimberly L Berk, Steven M Blum, Vanessa L Funk, et al.
Plos Genetics|February 6, 2014
Down-regulation of eIF4GII by miR-520c-3p represses diffuse large B cell lymphoma developmentKrystyna Mazan-Mamczarz, X Frank Zhao, Bojie Dai, et al.
JAMA Cardiology|August 25, 2016
Multicenter Study of Planar Technetium 99m Pyrophosphate Cardiac Imaging: Predicting Survival for Patients With ATTR Cardiac AmyloidosisAdam Castano, Muhammad Haq, David L Narotsky, et al.
Annals of Internal Medicine|January 22, 2004
High-dose melphalan and autologous stem-cell transplantation in patients with AL amyloidosis: an 8-year studyMartha Skinner, Vaishali Sanchorawala, David C Seldin, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|November 18, 2024
Effects of eplontersen on symptoms of autonomic neuropathy in hereditary transthyretin-mediated amyloidosis: secondary analysis from the NEURO-TTRansform trialJonas Wixner, John L Berk, David Adams, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|May 4, 2012
The Diflunisal Trial: study accrual and drug toleranceJohn L Berk, Ole B Suhr, Yoshiki Sekijima, et al.
Blood|August 11, 2011
Outcome of AL amyloidosis after high-dose melphalan and autologous stem cell transplantation: long-term results in a series of 421 patientsMaria Teresa Cibeira, Vaishali Sanchorawala, David C Seldin, et al.
Pageof 40

Showing results (351-360 of 398) with videos related to

Sort By:
Pageof 40
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|July 24, 2018
A library of ATTR amyloidosis patient-specific induced pluripotent stem cells for disease modelling and in vitro testing of novel therapeuticsRichard M Giadone, Jessica D Rosarda, Prithvi Reddy Akepati, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|August 16, 2011
The diflunisal trial: update on study drug tolerance and disease progressionJ L Berk, P J Dyck, L Obici, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 6, 2012
Phase I/IIa trial of the mammalian target of rapamycin inhibitor ridaforolimus (AP23573; MK-8669) administered orally in patients with refractory or advanced malignancies and sarcomaM M Mita, E Poplin, C D Britten, et al.
ACS Applied Materials & Interfaces|April 14, 2021
Rapid Visual Authentication Based on DNA Strand DisplacementKimberly L Berk, Steven M Blum, Vanessa L Funk, et al.
Plos Genetics|February 6, 2014
Down-regulation of eIF4GII by miR-520c-3p represses diffuse large B cell lymphoma developmentKrystyna Mazan-Mamczarz, X Frank Zhao, Bojie Dai, et al.
JAMA Cardiology|August 25, 2016
Multicenter Study of Planar Technetium 99m Pyrophosphate Cardiac Imaging: Predicting Survival for Patients With ATTR Cardiac AmyloidosisAdam Castano, Muhammad Haq, David L Narotsky, et al.
Annals of Internal Medicine|January 22, 2004
High-dose melphalan and autologous stem-cell transplantation in patients with AL amyloidosis: an 8-year studyMartha Skinner, Vaishali Sanchorawala, David C Seldin, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|November 18, 2024
Effects of eplontersen on symptoms of autonomic neuropathy in hereditary transthyretin-mediated amyloidosis: secondary analysis from the NEURO-TTRansform trialJonas Wixner, John L Berk, David Adams, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|May 4, 2012
The Diflunisal Trial: study accrual and drug toleranceJohn L Berk, Ole B Suhr, Yoshiki Sekijima, et al.
Blood|August 11, 2011
Outcome of AL amyloidosis after high-dose melphalan and autologous stem cell transplantation: long-term results in a series of 421 patientsMaria Teresa Cibeira, Vaishali Sanchorawala, David C Seldin, et al.
Pageof 40